US Stock MarketDetailed Quotes
NAUT Nautilus Biotechnology
- 2.270
- -0.020-0.87%
Trading Aug 9 09:33 ET
284.68MMarket Cap-4127P/E (TTM)
2.290High2.260Low605Volume2.290Open2.290Pre Close1.38KTurnover0.00%Turnover RatioLossP/E (Static)125.41MShares4.00052wk High1.21P/B94.87MFloat Cap2.19052wk Low--Dividend TTM41.79MShs Float25.886Historical High--Div YieldTTM1.31%Amplitude1.500Historical Low2.273Avg Price1Lot Size
Nautilus Biotechnology Stock Forum
Sign in to post a comment
$Inhibikase Therapeutics (IKT.US)$
$Inhibikase Therapeutics (IKT.US)$
$Inhibikase Therapeutics (IKT.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
The Company is completing 13-week pivotal toxicology studies to be submitted to the FDA for review in August.
CEO excised options
$CohBar (CWBR.US)$
$CohBar (CWBR.US)$
..........................................
$Fulcrum Therapeutics (FULC.US)$
$Inhibikase Therapeutics (IKT.US)$
$Inhibikase Therapeutics (IKT.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
The Company is completing 13-week pivotal toxicology studies to be submitted to the FDA for review in August.
CEO excised options
$CohBar (CWBR.US)$
$CohBar (CWBR.US)$
..........................................
$Fulcrum Therapeutics (FULC.US)$
7
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Klim5115 : Advantage of being rich and get richer by investment
HunterSparks : Nextdoor revolutionalises community living.Will be listed after merger with SPAC co KVSB with ticker symbol KIND .Very appropriate ticker symbol to its application.Can get exposure thru KVSB before listing